STOK - Stoke Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

STOK is currently covered by 9 analysts with an average price target of $23.88. This is a potential upside of $14.95 (167.41%) from yesterday's end of day stock price of $8.93.

Stoke Therapeutics's activity chart (see below) currently has 59 price targets and 78 ratings on display. The stock rating distribution of STOK is 94.59% BUY and 5.41% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 33.23% with an average time for these price targets to be met of 114.42 days.

Highest price target for STOK is $47, Lowest price target is $17, average price target is $22.29.

Most recent stock forecast was given by JOSEPH STRINGER from NEEDHAM on 08-Apr-2025. First documented stock forecast 14-Jul-2019.

Currently out of the existing stock ratings of STOK, 35 are a BUY (94.59%), 2 are a HOLD (5.41%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$22

$12.64 (135.04%)

$22

1 months 5 days ago
(08-Apr-2025)

5/21 (23.81%)

$15.57 (242.15%)

48

Buy

$47

$37.64 (402.14%)

$47

1 months 25 days ago
(18-Mar-2025)

0/10 (0%)

$38.74 (469.01%)

Buy

5 months 4 days ago
(09-Dec-2024)

1/5 (20%)

$8.45 (152.25%)

232

Buy

$17

$7.64 (81.62%)

$17

10 months 3 days ago
(10-Jul-2024)

2/6 (33.33%)

$2.97 (21.17%)

60

Buy

$20

$10.64 (113.68%)

$21

1 years 7 days ago
(06-May-2024)

0/3 (0%)

$8.06 (67.50%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is STOK (Stoke Therapeutics) average time for price targets to be met?

On average it took 114.42 days on average for the stock forecasts to be realized with a an average price target met ratio 33.23

Which analyst has the current highest performing score on STOK (Stoke Therapeutics) with a proven track record?

ALETHIA YOUNG

Which analyst has the most public recommendations on STOK (Stoke Therapeutics)?

Alethia Young works at CANTOR FITZGERALD and has 5 price targets and 5 ratings on STOK

Which analyst is the currently most bullish on STOK (Stoke Therapeutics)?

Michelle Gilson with highest potential upside - $67.64

Which analyst is the currently most reserved on STOK (Stoke Therapeutics)?

Martin Auster with lowest potential downside - -$0

Stoke Therapeutics in the News

CG Oncology, Inc. (CGON) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

CG Oncology, Inc. (CGON) is expected to deliver flat earnings compared to the year-ago quarter on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook gives a good sense of the company’s earnings picture, but how the actual results compare to these estimates is a powerful factor that...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?